1967
DOI: 10.1016/0002-9610(67)90343-1
|View full text |Cite
|
Sign up to set email alerts
|

Clinical and experimental use of gelatinized dacron grafts

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1973
1973
1995
1995

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 3 publications
0
1
0
Order By: Relevance
“…Bascom [1], Humphries et al [14], Jordan et al [15], Wesolowski el al. [31 ] and Chvapil and Kra jicek [3] all developed collagen-coated grafts during the sixties, but their clinical applica tion has remained limited [ 13,19], In fact, it is only recently that this concept of a colla gen-coated graft has reached a commercial stage with the introduction of the Hemashield® (Mcadox Medicals, Oakland, N.J.; USA) [24] and Tascon® prostheses (Tascon Medical Technology Corp. Irvine, Calif. USA). Other coatings have been proposed for the manufacture of compound arterial prostheses.…”
Section: Introductionmentioning
confidence: 99%
“…Bascom [1], Humphries et al [14], Jordan et al [15], Wesolowski el al. [31 ] and Chvapil and Kra jicek [3] all developed collagen-coated grafts during the sixties, but their clinical applica tion has remained limited [ 13,19], In fact, it is only recently that this concept of a colla gen-coated graft has reached a commercial stage with the introduction of the Hemashield® (Mcadox Medicals, Oakland, N.J.; USA) [24] and Tascon® prostheses (Tascon Medical Technology Corp. Irvine, Calif. USA). Other coatings have been proposed for the manufacture of compound arterial prostheses.…”
Section: Introductionmentioning
confidence: 99%